Omics as a window to view embryo viability
Omics technologies offer several noninvasive platforms for the investigation of biomarkers for embryo viability.
Rebecca L. Krisher, Ph.D., William B. Schoolcraft, M.D., Mandy G. Katz-Jaffe, Ph.D.
Volume 102, Issue 3, Pages 333-341
The advent of advanced omics technologies and the application of these techniques to the analysis of extremely limited material have opened the door to the investigation of embryo physiology in a focused, in-depth approach never before possible. The application of noninvasive metabolomic and proteomic platforms to understanding embryo viability permits the characterization of individual embryos in culture. Initial clinical data have highlighted the promise of these technologies for the development of noninvasive embryo selection criteria. In this way, a complex view of embryo function can be compiled and related to embryo development, quality, and outcome. Application of knowledge gained from omics will transform both our understanding of embryo physiology as well as our ability to select viable embryos for transfer in assisted reproductive technology.